Eric D. Shaff is a director of Sigilon Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Seres Therapeutics, Inc.
19 Aug 24
4
Seres Therapeutics, Inc.
17 May 24
4
Seres Therapeutics, Inc.
16 Feb 24
4
Seres Therapeutics, Inc.
31 Oct 23
4
Sigilon Therapeutics, Inc.
11 Aug 23
4
Sigilon Therapeutics, Inc.
22 May 23
4
Seres Therapeutics, Inc.
7 Feb 23
4
Seres Therapeutics, Inc.
6 Jul 22
4
Sigilon Therapeutics, Inc.
27 May 22
4
Seres Therapeutics, Inc.
8 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Aug 24 | MCRB Seres Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 0.84 | 2,518 | 2.12 k | 145,993 |
15 Aug 24 | MCRB Seres Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 7,813 | 0.00 | 148,511 |
15 Aug 24 | MCRB Seres Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 7,813 | 0.00 | 78,125 |
15 May 24 | MCRB Seres Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 0.94 | 2,435 | 2.29 k | 140,698 |
15 May 24 | MCRB Seres Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 7,812 | 0.00 | 143,133 |
15 May 24 | MCRB Seres Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 7,812 | 0.00 | 85,938 |
16 Feb 24 | MCRB Seres Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 1.08 | 11,549 | 12.47 k | 135,321 |
15 Feb 24 | MCRB Seres Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 31,250 | 0.00 | 146,870 |
15 Feb 24 | MCRB Seres Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 31,250 | 0.00 | 93,750 |
14 Feb 24 | MCRB Seres Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 106,250 | 0.00 | 106,250 |